49, (! %B! ):6;+*.2:8!S!43*+*-.!.,H0-<<-.!-2!<-03(! %N! 1. Stevens A, Johnson F. A new eruptive fever associated with stomatitis and ophtalmiaT: report of two cases in children, pp.867-869, 1922. ,
TOXIC EPIDERMAL NECROLYSIS: AN ERUPTION RESEMBLING SCALDING OF THE SKIN., British Journal of Dermatology, vol.30, issue.11, pp.355-61, 1956. ,
DOI : 10.1111/j.1365-2133.1956.tb12766.x
Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme, Archives of Dermatology, vol.129, issue.1, pp.92-98, 1993. ,
DOI : 10.1001/archderm.1993.01680220104023
Medication Use and the Risk of Stevens???Johnson Syndrome or Toxic Epidermal Necrolysis, New England Journal of Medicine, vol.333, issue.24, pp.1600-1607, 1995. ,
DOI : 10.1056/NEJM199512143332404
Toxic epidermal necrolysis (Lyell syndrome), Journal of the American Academy of Dermatology, vol.23, issue.6, pp.1039-58, 1990. ,
DOI : 10.1016/0190-9622(90)70333-D
Drugs involved in toxic epidermal necrolysis (Lyell's syndrome) ,
N??crolyse ??pidermique : M??canisme de l???apoptose des k??ratinocytes, m??decine/sciences, vol.22, issue.2, pp.188-91, 2006. ,
DOI : 10.1051/medsci/2006222188
syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study, J Invest Dermatol, vol.128, pp.35-44, 2008. ,
Erythema Multiforme With Mucous Membrane Involvement and Stevens-Johnson Syndrome Are Clinically Different Disorders With Distinct Causes, Archives of Dermatology, vol.131, issue.5, pp.539-582, 1995. ,
DOI : 10.1001/archderm.1995.01690170041005
Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.138, issue.8, pp.1019-1043, 2002. ,
DOI : 10.1001/archderm.138.8.1019
Lyell's toxic epidermal necrolysis: histologic aspects], Arch Belg Dermatol Syphiligr, vol.26, pp.97-114, 1970. ,
Drug-induced toxic epidermal necrolysis. I. An overview, Clinics in Dermatology, vol.11, issue.4, pp.491-493, 1993. ,
DOI : 10.1016/0738-081X(93)90155-6
Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: Our Current Understanding, Allergology International, vol.55, issue.1, pp.9-16, 2006. ,
DOI : 10.2332/allergolint.55.9
URL : http://doi.org/10.2332/allergolint.55.9
Toxic epidermal necrolysis and Stevens-Johnson syndrome], Rev Prat, vol.57, pp.1165-70, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00624798
Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study, The Lancet, vol.353, issue.9171, pp.2190-2194, 1999. ,
DOI : 10.1016/S0140-6736(98)05418-X
Toxic Epidermal Necrolysis in Singapore, 1989 Through 1993: Incidence and Antecedent Drug Exposure, Archives of Dermatology, vol.131, issue.10, pp.1212-1215, 1989. ,
DOI : 10.1001/archderm.1995.01690220120030
Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis New-York: Fitzpatrick's Dermatology in General Medicine, pp.543-57, 2003. ,
Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital, Journal of the American Academy of Dermatology, vol.40, issue.3, pp.493-499, 1999. ,
DOI : 10.1016/S0190-9622(99)70508-6
Toxic Epidermal Necrolysis in Patients Receiving Anticonvulsants and Cranial Irradiation: A Risk to Consider, Journal of Neuro-Oncology, vol.66, issue.3, pp.345-50, 2004. ,
DOI : 10.1023/B:NEON.0000014538.31561.bc
Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin, Journal of the European Academy of Dermatology and Venereology, vol.103, issue.5, pp.588-90, 2006. ,
DOI : 10.1159/000079094
Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipient, Bone Marrow Transplantation, vol.30, issue.5, pp.331-334, 2002. ,
DOI : 10.1038/sj.bmt.1703624
Erythema multiforme and Stevens-Johnson syndrome. London: Mosby, pp.313-333, 2003. ,
Toxic epidermal necrolysis. London: Mosby, pp.323-354, 2003. ,
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience, Drug Saf Int J Med Toxicol Drug Exp, vol.25, pp.965-72, 2002. ,
Lupus-associated toxic epidermal necrolysis: A novel manifestation of lupus?, Journal of the American Academy of Dermatology, vol.48, issue.4, pp.525-534, 2003. ,
DOI : 10.1067/mjd.2003.107
Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection, Allergy, vol.59, issue.1, p.118, 2004. ,
DOI : 10.1001/archderm.136.3.323
Clues to Pathogenesis of Toxic Epidermal Necrolysis, International Journal of Dermatology, vol.132, issue.3, pp.165-173, 1985. ,
DOI : 10.1001/archderm.98.5.528
T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis, Archives of Dermatology, vol.127, issue.6 ,
DOI : 10.1001/archderm.1991.01680050095011
Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases, Archives of Dermatology, vol.128, issue.1, pp.50-53, 1992. ,
DOI : 10.1001/archderm.128.1.50
Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement, Archives of Dermatology, vol.129, issue.4, pp.466-474, 1993. ,
DOI : 10.1001/archderm.129.4.466
Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis, British Journal of Dermatology, vol.91, issue.4, pp.710-714, 1996. ,
DOI : 10.1016/0167-5699(94)90249-6
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis, Archives of Dermatology, vol.130, issue.5, pp.605-613, 1994. ,
DOI : 10.1001/archderm.130.5.605
Soluble fractions of tumor necrosis factor-alpha, p.6 ,
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin, Science, vol.282, issue.5388, pp.490-493, 1998. ,
DOI : 10.1126/science.282.5388.490
Intravenous Immunoglobulin Treatment for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.139, issue.1, pp.33-39, 2003. ,
DOI : 10.1001/archderm.139.1.33
Toxic epidermal necrolysis: does immunoglobulin make a difference?, J Burn Care Rehabil, vol.25, pp.81-89, 2004. ,
Intravenous Immunoglobulin Does Not Improve Outcome in Toxic Epidermal Necrolysis, Journal of Burn Care & Rehabilitation, vol.25, issue.3, pp.246-55, 2004. ,
DOI : 10.1097/01.BCR.0000124746.33279.86
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Are Induced by Soluble Fas Ligand, The American Journal of Pathology, vol.162, issue.5, pp.1515-1535, 2003. ,
DOI : 10.1016/S0002-9440(10)64284-8
Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin, International Journal of Molecular Medicine, vol.10, pp.145-152, 2002. ,
DOI : 10.3892/ijmm.10.2.145
Medical genetics: A marker for Stevens???Johnson syndrome, Nature, vol.428, issue.6982, pp.486-534, 2004. ,
DOI : 10.1038/428486a
Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis, Cornea, vol.26, issue.2, pp.123-132, 2007. ,
DOI : 10.1097/ICO.0b013e31802eb264
Diagnosis and Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Complications, Ophthalmology, vol.116, issue.4, pp.685-90, 2009. ,
DOI : 10.1016/j.ophtha.2008.12.048
Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study, Intensive Care Medicine, vol.123, issue.12, pp.1237-1281, 1997. ,
DOI : 10.1007/s001340050492
Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients, Archives of Dermatology, vol.123, issue.9, pp.1160-1165, 1987. ,
DOI : 10.1001/archderm.123.9.1160
Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy, J Rheumatol, vol.10, pp.512-515, 1983. ,
A Multicenter Review of Toxic Epidermal Necrolysis Treated in U.S. Burn Centers at the End of the Twentieth Century, Journal of Burn Care & Rehabilitation, vol.23, issue.2, pp.87-96, 2002. ,
DOI : 10.1097/00004630-200203000-00004
Long-Term Follow-Up of Patients Treated for Toxic Epidermal Necrolysis, Journal of Burn Care & Research, vol.27, issue.1, pp.26-33, 2006. ,
DOI : 10.1097/01.bcr.0000194268.01514.f8
Toxic Epidermal Necrolysis Syndrome: Mortality Rate Reduced with Early Referral to Regional Burn Center, Plastic and Reconstructive Surgery, vol.102, issue.4, pp.1018-1040, 1998. ,
DOI : 10.1097/00006534-199809020-00014
Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg), Drugs, vol.25, issue.15, pp.2085-90, 2005. ,
DOI : 10.2165/00003495-200565150-00002
Management of toxic epidermal necrolysis and related syndromes, Postgraduate Medical Journal, vol.84, issue.988, pp.60-65, 2008. ,
DOI : 10.1136/pgmj.2007.061465
Dermatological and Ophthalmological Sequels in Toxic Epidermal Necrolysis, Dermatology, vol.207, issue.1, pp.33-39, 2003. ,
DOI : 10.1159/000070938
Long-Term Consequences of Toxic Epidermal Necrolysis in Children, PEDIATRICS, vol.109, issue.1, pp.74-82, 2002. ,
DOI : 10.1542/peds.109.1.74
Ocular manifestations and complications of Stevens?Johnson syndrome and toxic epidermal necrolysis: an Asian series, Allergy, vol.95, issue.5, pp.527-558, 2007. ,
DOI : 10.1038/sj.eye.6701653
Available from: http://www.hassante .fr/portail/upload/docs/application/pdf/2011-01/ald_31_pnds_sjs_lyell_web.pdf 64, 2010. ,
Toxic epidermal necrolysis in a burns centre: A 6-year review, Burns, vol.22, issue.4 ,
DOI : 10.1016/0305-4179(95)00140-9
S??quelles cutan??omuqueuses et oculaires des SJS et de Lyell, Annales de Dermatologie et de V??n??r??ologie, vol.138, issue.2, pp.88-92, 2011. ,
DOI : 10.1016/j.annder.2010.10.029
Late Outcomes in Adult Survivors of Toxic Epidermal Necrolysis After Treatment in a Burn Center, Journal of Burn Care & Rehabilitation, vol.26, issue.1, pp.33-41, 2005. ,
DOI : 10.1097/01.BCR.0000150215.78220.79
Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990???1992): Structure and results of a population-based registry, Journal of Clinical Epidemiology, vol.49, issue.7, pp.769-73, 1996. ,
DOI : 10.1016/0895-4356(96)00035-2
Toxic Epidermal Necrolysis (Lyell Syndrome), Archives of Dermatology, vol.126, issue.1, pp.37-42, 1981. ,
DOI : 10.1001/archderm.1990.01670250043005
Syndrome de LyellT: à propos de 17 cas étudiés de 1980 à 1985 dans le service des brûlés de Bordeaux, 1987. ,
Acquired Labial Sinechiae and Hydrocolpos Secondary to Stevens-Johnson Syndrome, Urology, vol.80, issue.4, pp.919-940, 2012. ,
DOI : 10.1016/j.urology.2012.06.051
Vaginal Adhesions Caused by Stevens-Johnson Syndrome, Journal of Pediatric and Adolescent Gynecology, vol.15, issue.3, pp.151-153, 2002. ,
DOI : 10.1016/S1083-3188(02)00146-8
Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology, Archives of Gynecology and Obstetrics, vol.105, issue.2, pp.851-855, 2009. ,
DOI : 10.1007/s00404-009-1008-1
Vulvovaginal sequelae of Stevens-Johnson syndrome and their management, Obstet Gynecol, vol.71, pp.478-80, 1988. ,
Vulvovaginal Involvement in Toxic Epidermal Necrolysis: A Retrospective Study of 40 Cases, Obstetrics & Gynecology, vol.91, issue.2, pp.283-290, 1998. ,
DOI : 10.1016/S0029-7844(97)00596-6
A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center, Mil Med, vol.167, pp.701-705, 2002. ,
Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients, Acta Derm Venereol, vol.85, pp.497-502, 2005. ,
Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases, J Am Acad Dermatol, vol.13, pp.623-658, 1985. ,
Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum, Dermatol Clin, vol.10, pp.571-82, 1992. ,
Correlation of Corneal Complications with Eyelid Cicatricial Pathologies in Patients with Stevens???Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome, Ophthalmology, vol.112, issue.5, pp.904-916, 2005. ,
DOI : 10.1016/j.ophtha.2004.11.035
Retrospective analysis of stevensjohnson syndrome and toxic epidermal necrolysis over a period of 10 years, Indian J Dermatol, vol.56, pp.25-34, 2011. ,
Risk Factors for the Development of Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.145, issue.2, pp.157-62, 2009. ,
DOI : 10.1001/archdermatol.2009.540
Stevens???Johnson syndrome: Pathogenesis, diagnosis, and management, Annals of Medicine, vol.138, issue.2, pp.129-167, 2008. ,
DOI : 10.1038/sj.jid.5700068
Toxic epidermal necrolysis: Review of pathogenesis and management, Journal of the American Academy of Dermatology, vol.66, issue.6, pp.995-1003, 2012. ,
DOI : 10.1016/j.jaad.2011.09.029
A systematic review of the druginduced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population ,
Chronic pulmonary complications associated with toxic epidermal necrolysis: Report of a severe case with anti-Ro/SS-A and a review of the published work, The Journal of Dermatology, vol.148, issue.9, pp.616-638, 2006. ,
DOI : 10.1111/j.1600-0560.1995.tb01420.x
Toxic epidermal necrolysis with a rare long-term oral complication requiring surgical intervention, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.105, issue.4, pp.29-33, 2008. ,
DOI : 10.1016/j.tripleo.2007.12.023